Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus

✍ Scribed by G. Luippold; T. Klein; M. Mark; R. Grempler

• Book ID: 115185044
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 701 KB
• Volume: 14
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/j.1463-1326.2012.01569.x